Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS

The LDL to HDL Cholesterol Ratio as a Valuable Tool to Evaluate Coronary Heart Disease Risk

(2013) Maria Luz Fernandez et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids

(2011) M. B. Sasongko et al.   DIABETES CARE

Lipoprotein profiles in Mexican American and non-Hispanic white women with polycystic ovary syndrome

(2011) Robert P. Kauffman et al.   FERTILITY AND STERILITY

Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis

(2011) Robert A. Wild et al.   FERTILITY AND STERILITY

Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40

(2011) S.-J. Liang et al.   HUMAN REPRODUCTION

Targeting endogenous apo A-I—a new approach for raising HDL

(2011) Prediman K. Shah   Nature Reviews Cardiology

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

(2011) Mohamad Navab et al.   Nature Reviews Cardiology

Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS

(2011) Ping Fan et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

(2010) H Teede et al.   BMC Medicine

Association of Apolipoprotein B with Incident Type 2 Diabetes in an Aboriginal Canadian Population

(2010) S. H. Ley et al.   CLINICAL CHEMISTRY

Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents

(2010) Yong-ho Lee et al.   CLINICAL ENDOCRINOLOGY

Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors

(2010) Michelle P. Rocha et al.   GYNECOLOGICAL ENDOCRINOLOGY

Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome

(2010) Ping Fan et al.   HUMAN REPRODUCTION

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein

(2010) P. J. W. H. Kappelle et al.   JOURNAL OF INTERNAL MEDICINE

Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria

(2010) M. Guo et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome

(2009) Ren-min Ni et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome

(2009) Ping Fan et al.   FERTILITY AND STERILITY

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

(2009) W. A. March et al.   HUMAN REPRODUCTION

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

(2009) Lisa Moran et al.   HUMAN REPRODUCTION UPDATE

Lipid and lipoprotein profile in women with polycystic ovary syndromeThis article is one of a selection of papers published in the special issue Bridging the Gap: Where Progress in Cardiovascular and Neurophysiologic Research Meet.

(2008) Djuro Macut et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

(2008) J. Sierra-Johnson et al.   EUROPEAN HEART JOURNAL

Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome

(2008) L.P. Cheung et al.   HUMAN REPRODUCTION

Polycystic ovary syndrome in adolescents

(2008) S Franks   INTERNATIONAL JOURNAL OF OBESITY

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation

(2008) Leslee J. Shaw et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Looking for Polycystic Ovary Syndrome Genes: Rational and Best Strategy

(2008) Mark Goodarzi   SEMINARS IN REPRODUCTIVE MEDICINE

Cardiovascular Disease Risk Factors in Polycystic Ovary Syndrome

(2008) Anuja Dokras   SEMINARS IN REPRODUCTIVE MEDICINE

A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study

(2007) Olivier Valkenburg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM